Psoriatic Arthritis
Psoriatic Arthritis (PsA) is a chronic autoimmune disease characterized by inflammatory arthritis often associated with the skin condition psoriasis, and it may present with swollen, sausage-like fingers and toes, as well as changes in the nails. While there is no cure, treatments can alleviate pain, reduce inflammation, and prevent joint dysfunction.
Health Outcomes
- Altered T Cell Migratory Behavior
- Elevated Interleukin-6 Levels
- Enhanced Anti-inflammatory Response
- Improved ACR20 Response
- Improved Clinical Disease Activity
- Improved Disease Activity Index Score
- Improved Immunomodulation
- Improved Joint Function
- Improved Orthopedic Function
- Improved Patient Global Assessment
- Improved Physician Global Assessment
- Improved Responder Rate
- Improved Specific Elements Within Assessed Measures
- Improved Stiffness
- Improved Symptom Control in Degenerative Joint Disease
- Improved Tissue Pathology
- Increased Anti-Osteoclastogenic Cytokine Production
- Increased Antigen-Presenting Cell Activation
- Increased Complement C3 Level
- Increased Hyaluronic Acid Molecular Weight
- Increased IL-12 Production
- Increased Inflammatory Mediator Production
- Increased Regulatory T Cell Expansion
- Increased Regulatory T Cell Response
- Increased T Cell Activation
- Increased Th1-Associated Cytokine Release
- Increased Uric Acid
- Inflammatory Disease Protection
- Modulated Humoral Inflammation
- No Change in C-Reactive Protein
- No Meaningful Change in IL-8
- No Significant Change in Tumor Necrosis Factor Alpha Levels
- No Significant Effect on C-Reactive Protein Levels
- Reduced Arthritis Incidence
- Reduced Arthritis Score
- Reduced Arthritis Severity
- Reduced Arthritis Symptoms
- Reduced Bone Erosion
- Reduced Clinical Symptoms of Arthritis
- Reduced Disease Activity
- Reduced Disease Activity Index (DAI) Levels
- Reduced IL-8 Secretion
- Reduced Immune Activation
- Reduced Inflammatory Marker IL-1β
- Reduced Inflammatory Pathways
- Reduced Inflammatory Response to Inflammatory Stimulus
- Reduced Inflammatory Stimulators
- Reduced Interleukin-1β Levels
- Reduced Joint Damage
- Reduced Joint Inflammation
- Reduced Joint Swelling
- Reduced Joint Tenderness
- Reduced Knee Pain
- Reduced Pain During Movement
- Reduced Pro-Inflammatory Factor TNF-α
- Reduced Pro-Inflammatory Immune Activity
- Reduced Pro-Inflammatory Mediator Production
- Reduced Psoriasis Symptoms
- Reduced Steroid Load
- Reduced Susceptibility to Inflammatory Exposure
- Reduced Swelling
- Reduced Swollen Joint Count
- Reduced Synovial Infiltration
- Reduced TNF-alpha Level
- Reduced Tender Joint Count
- Reduced Tumor Necrosis Factor-alpha Level
- Reduced Tumor Necrosis Factor-α Levels
- Reduced hsCRP Level
- Suppressed Inflammatory Chemokine Secretion
- Suppressed TNF-α Induced Genes